Stephen Chia
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
- Oncology 114
- HER2/EGFR in Cancer Research 57
- Cancer Treatment and Pharmacology 50
- Lung Cancer Research Studies 9
-
- Breast Cancer Treatment Studies 76
- Cancer Genomics and Diagnostics 23
- Co-authors
- Torsten O. Nielsen (22 shared papers)Maggie C.U. Cheang (16 shared papers)Samuel Leung (12 shared papers)Charles M. Perou (8 shared papers)Karen A. Gelmon (51 shared papers)David Voduc (4 shared papers)Chris Bajdik (11 shared papers)Caroline Speers (21 shared papers)
- Journals
- Journal of Clinical Oncology (65 papers)Cancer Research (23 papers)Annals of Oncology (21 papers)Breast Cancer Research and Treatment (12 papers)Clinical Cancer Research (11 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Stephen Chia
225 papers receiving 11.8k citations
Stephen Chia's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 4.9k
- Oncology 5.3k
- Pulmonary and Respiratory Medicine 2.4k
- Pathology and Forensic Medicine 787
- Molecular Biology 2.7k
Countries citing papers authored by Stephen Chia
This map shows the geographic impact of Stephen Chia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Chia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Chia more than expected).
Fields of papers citing papers by Stephen Chia
This network shows the impact of papers produced by Stephen Chia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Chia. The network helps show where Stephen Chia may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Chia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer Hit paper breakdown → | 2009 | 1706 |
| 2 | Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype Hit paper breakdown → | 2008 | 978 |
| 3 | Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Hit paper breakdown → | 2013 | 821 |
| 4 | 2005 | 444 | |
| 5 | 2008 | 388 | |
| 6 | 2001 | 378 | |
| 7 | 2007 | 353 | |
| 8 | 2012 | 239 | |
| 9 | 2008 | 238 | |
| 10 | Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study Hit paper breakdown → | 2021 | 236 |
| 11 | 2016 | 236 | |
| 12 | 2009 | 226 | |
| 13 | 2001 | 216 | |
| 14 | 2009 | 186 | |
| 15 | Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Hit paper breakdown → | 2021 | 174 |
| 16 | 2017 | 173 | |
| 17 | 2006 | 163 | |
| 18 | 2017 | 152 | |
| 19 | 2009 | 150 | |
| 20 | 2004 | 135 |
About Stephen Chia
Stephen Chia is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 233 papers that have together received 12.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (83 papers), Breast Cancer Treatment Studies (76 papers), HER2/EGFR in Cancer Research (57 papers), Cancer Treatment and Pharmacology (50 papers), Cancer Genomics and Diagnostics (23 papers), Estrogen and related hormone effects (15 papers), Lung Cancer Research Studies (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Cancer Research (4.9k citations), Oncology (5.3k citations), Pulmonary and Respiratory Medicine (2.4k citations), Pathology and Forensic Medicine (787 citations) and Molecular Biology (2.7k citations). Stephen Chia has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Torsten O. Nielsen, Maggie C.U. Cheang, Samuel Leung, Charles M. Perou, Karen A. Gelmon, David Voduc, Chris Bajdik, Caroline Speers, Dongxia Gao and Ivo A. Olivotto. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.